Nuria Revenga-Vegas
Galdakao, PV 48960, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Leukocyte Telomere Length and Long-Term Clinical Outcomes in Women with Systemic Lupus Erythematosus: A Prospective Cohort Study.
Journal: Journal of clinical medicine
Published: May 14, 2026
Prevalence of Metabolic-Dysfunction-Associated Steatotic Liver Disease in Patients with Psoriasis and Psoriatic Arthritis.
Journal: Diagnostics (Basel, Switzerland)
Published: April 29, 2026
Long-term vascular outcomes and biological predictors of thrombosis in systemic lupus erythematosus: a 10-year prospective cohort study.
Journal: European journal of internal medicine
Published: April 07, 2026
The economic burden of moderate-to-severe rheumatoid arthritis in Spain: the CIARA study.
Journal: Journal of medical economics
Published: March 31, 2026
Validation of screening criteria for interstitial lung disease in rheumatoid arthritis in routine clinical practice: the VAR-EPIDSER study.
Journal: RMD open
Published: March 10, 2026
Baricitinib in rheumatoid arthritis-interstitial lung disease: a literature review and national multicentre study of 72 patients.
Journal: Rheumatology (Oxford, England)
Published: January 22, 2025
Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients.
Journal: Seminars in arthritis and rheumatism
Published: January 07, 2025
Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients.
Journal: Seminars in arthritis and rheumatism
Published: March 04, 2024
Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients.
Journal: Seminars in arthritis and rheumatism
Published: February 03, 2023
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis.
Journal: Frontiers in immunology
Published: March 11, 2022
Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363.
Journal: Diagnostics (Basel, Switzerland)
Published: December 29, 2021
SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis.
Journal: Diagnostics (Basel, Switzerland)
Published: November 22, 2021
Last Updated: 09/26/2026